Grace Therapeutics
在场
Grace Therapeutics 的所有者是 Neptune Wellness Solutions.
Neptune Wellness Solutions 是一家在股票代码 NEPT (CA) 下上市的公司。
他们在：
涉及Neptune Wellness Solutions的并购和融资。
- Grace Therapeutics将在Oct 25, 2024将其名称改为Grace Therapeutics。 (公布2024十月27号).
高管
查看带有其 8 名主要高管的组织结构图
Grace Therapeutics 搜索最多的简介
高管在Neptune Wellness Solutions变化
- Cedrick Billequey 曾任 General Manager of Biodroga Nutraceuticals, Inc, 现任 Interim Chief Operating Officer and General Manager of Biodroga Nutraceuticals, Inc (新闻发布的2024八月9号).
- Michael de Geus 曾任 Director, 现升职为 Interim President and Chief Executive Officer (新闻发布的2024三月11号).
- Michael Cammarata, President, Chief Executive Officer and Director, 已经离开公司 (新闻发布的2024三月5号).
创建提醒
跟踪 Grace Therapeutics 的高管变动
药店
Neptune Wellness Solutions 拥有 1,842 家竞争者，其中包括 Pfizer (美国(美洲))、Johnson & Johnson (美国(美洲)) 和 Sanofi (法国)。
Popular M&A news in 药店
- BeiGene将改名为BeOne Medicines。 (公布2024十一月15号).
- GlycoMimetics and Crescent Biopharma have announced they will merge (公布2024十一月15号)..
- Grace Therapeutics将在Oct 25, 2024将其名称改为Grace Therapeutics。 (公布2024十月27号).
药店 行业的其他推荐联系人
消息
Grace Therapeutics 的最新新闻稿
- Grace Therapeutics Announces Second Fiscal Quarter 2025 Financial Results, Provides Business Update
- Grace Therapeutics to Host Virtual KOL Event on GTx-104 in aneurysmal Subarachnoid Hemorrhage on November 20, 2024
- Acasti Announces Completion of Patient Enrollment in Pivotal Phase 3 STRIVE-ON Safety Trial of GTX-104
- Acasti to Present at the Life Sciences Investor Forum
- Acasti to Participate in the H.C. Wainwright 26th Annual Global Investment Conference
- Acasti Announces First Fiscal Quarter 2025 Financial Results, Provides Business Update
- Acasti Announces Year-End 2024 Financial Results, Provides Business Update
- Acasti Announces Achievement of 50% Enrollment in Pivotal Phase 3 STRIVE-ON Safety Trial
- Acasti Pharma to Attend BIO International Convention 2024
- Acasti Announces Third Fiscal Quarter 2024 Financial Results and Business Highlights
- View more press releases Close
通过电子邮件
